|

Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

RECRUITINGSponsored by University Health Network, Toronto
Actively Recruiting
SponsorUniversity Health Network, Toronto
Started2020-07-15
Est. completion2027-03
Eligibility
Age19 Years+
View on ClinicalTrials.gov →

NCT04526093

Summary

This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.

Eligibility

Age: 19 Years+
Inclusion Criteria:

* Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
* Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
* Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study

Exclusion Criteria:

* Concomitant use of illicit drugs
* Concomitant use of recreational cannabis

Conditions5

AnxietyDepressionEpilepsyPainSleep

Browse More Trials

Depression trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.